Therapeutic dosage assessment based on population pharmacokinetics of a novel single-dose transdermal donepezil patch in healthy volunteers
暂无分享,去创建一个
Hyeong-Seok Lim | Yo Han Kim | H. Choi | K. Bae | D. Hong | Seong Su Kim
[1] Hyeong-Seok Lim,et al. Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers , 2015, Drug design, development and therapy.
[2] Matthias J. Müller,et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. , 2014, Pharmacopsychiatry.
[3] Muriel Noetzli,et al. Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance. , 2014, British journal of clinical pharmacology.
[4] A. Banga,et al. A novel electronic skin patch for delivery and pharmacokinetic evaluation of donepezil following transdermal iontophoresis. , 2013, International journal of pharmaceutics.
[5] Y. Yamada,et al. Population Pharmacokinetics of Transdermal Fentanyl in Patients With Cancer-Related Pain , 2012, Journal of pain & palliative care pharmacotherapy.
[6] Matthias J. Müller,et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. , 2014, Pharmacopsychiatry.
[7] T. Suhara,et al. Estimation of Plasma IC50 of Donepezil for Cerebral Acetylcholinesterase Inhibition in Patients With Alzheimer Disease Using Positron Emission Tomography , 2010, Clinical neuropharmacology.
[8] K. Bley,et al. Pharmacokinetic Analysis of Capsaicin After Topical Administration of a High-Concentration Capsaicin Patch to Patients With Peripheral Neuropathic Pain , 2009, Therapeutic drug monitoring.
[9] L. Ereshefsky,et al. Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice‐daily Capsules in Alzheimer's Disease Patients , 2008, Clinical pharmacology and therapeutics.
[10] W. Oertel,et al. Rationale for transdermal drug administration in Alzheimer disease , 2007, Neurology.
[11] B. Winblad,et al. A six‐month double‐blind, randomized, placebo‐controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch versus capsule , 2007, International journal of geriatric psychiatry.
[12] L. Minthon,et al. Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer’s disease following chronic donepezil treatment , 2006, Journal of Neural Transmission.
[13] Soo-Youn Lee,et al. Sequence-based CYP2D6 Genotyping in the Korean Population , 2006, Therapeutic drug monitoring.
[14] C. Perdomo,et al. Steady-state pharmacokinetics, pharmacodynamics and tolerability of donepezil hydrochloride in hepatically impaired patients. , 2004, British journal of clinical pharmacology.
[15] N. Relkin,et al. A Large, Community-Based, Open-Label Trial of Donepezil in the Treatment of Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.
[16] K. Någren,et al. Regional Effects of Donepezil and Rivastigmine on Cortical Acetylcholinesterase Activity in Alzheimer’s Disease , 2002, Journal of clinical psychopharmacology.
[17] Cooper,et al. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses: Multiple oral doses of donepezil , 2002 .
[18] L. Friedhoff,et al. Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses. , 2002, British journal of clinical pharmacology.
[19] Dirk Deleu,et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. , 2001, Neurology.
[20] B. Winblad,et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD , 2001, Neurology.
[21] K. Hasegawa,et al. Clinical Efficacy and Safety of Donepezil on Cognitive and Global Function in Patients with Alzheimer’s Disease , 2000, Dementia and Geriatric Cognitive Disorders.
[22] L. Friedhoff,et al. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration. , 1998, British journal of clinical pharmacology.
[23] L. Friedhoff,et al. Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study. , 1998, British journal of clinical pharmacology.
[24] L. Friedhoff,et al. Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses. , 1998, British journal of clinical pharmacology.
[25] X. Tang,et al. Comparative Studies of Huperzine A, E2020, and Tacrine on Behavior and Cholinesterase Activities , 1998, Pharmacology Biochemistry and Behavior.
[26] E. Giacobini,et al. The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex , 1996, Neuropharmacology.
[27] A. Ohnishi,et al. Comparison of the Pharmacokinetics of E2020, A New Compound for Alzheimer's Disease, in Healthy Young and Elderly Subjects , 1993, Journal of clinical pharmacology.
[28] H. Owen,et al. The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems , 1990, Pain.
[29] G. Flynn,et al. Transdermal Delivery of Narcotic Analgesics: Comparative Permeabilities of Narcotic Analgesics Through Human Cadaver Skin , 1989, Pharmaceutical Research.
[30] D. Stanski,et al. Absorption characteristics of transdermally administered fentanyl. , 1989, Anesthesiology.
[31] J. Plummer,et al. The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects , 1989, Pain.
[32] G. Small,et al. Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase Inhibitors , 2002, Clinical pharmacokinetics.
[33] L. Radbruch,et al. Clinical Pharmacokinetics of Transdermal Opioids , 2000, Clinical pharmacokinetics.
[34] L. Friedhoff,et al. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses. , 1998, British journal of clinical pharmacology.
[35] L. Friedhoff,et al. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses. , 1998, British journal of clinical pharmacology.
[36] E. Tur,et al. Physiology of the skin--differences between women and men. , 1997, Clinics in dermatology.